Encapsulated Allografts Preclude Host Sensitization and Promote Ovarian Endocrine Function in Ovariectomized Young...

Area of Science:

• Reproductive biology
• Biomaterials science
• Immunology

Background:

• Female cancer survivors often face premature ovarian insufficiency.
• Ovarian tissue transplantation is a potential fertility preservation method.
• Immune rejection and sensitization are major challenges in allogeneic transplantation.

Purpose of the Study:

• To develop an immunoisolating hydrogel capsule for ovarian allografts.
• To evaluate the function and immune response of encapsulated ovarian allografts.
• To assess the translational potential of the capsule in a primate model.

Main Methods:

• Development of a hydrogel-based immunoisolating capsule.
• Implantation of encapsulated and non-encapsulated ovarian allografts in mice.
• Assessment of ovarian function via estrous cycles and follicle presence.
• Evaluation of immune response through alloantibody detection.
• Testing encapsulated ovarian auto- and allografts in rhesus monkeys.

Main Results:

• Encapsulated ovarian allografts maintained function for 4 months in mice, evidenced by regular estrous cycles and antral follicles.
• Encapsulated grafts did not sensitize recipient mice, with undetectable alloantibody levels.
• Encapsulated ovarian grafts restored hormone levels in ovariectomized rhesus monkeys for up to 5 months.
• The immunoisolating capsule successfully prevented allograft rejection and host sensitization.

Conclusions:

• The hydrogel-based immunoisolating capsule supports functional ovarian allografts.
• This technology prevents immune rejection and sensitization, offering a promising approach for fertility preservation.
• Encapsulated ovarian transplantation shows translational potential in preclinical models.